Literature DB >> 22514458

Seroprevalence of toxoplasma antibody in a Toronto population.

E Ford-Jones1, I Kitai, M Corey, R Notenboom, N Hollander, E Kelly, H Akoury, G Ryan, I Kyle, R Gold.   

Abstract

OBJECTIVE: To determine the prevalence of infection with toxoplasmosis by country of birth and age in a sample of convenience.
DESIGN: Banked sera and the computerized data base of demographic and other factors from an earlier epidemiological study were retrieved.
SETTING: Thirty-eight infant-toddler day care centres in Toronto. POPULATION: Day care providers from whom informed consent was obtained and banked sera were available. MAIN
RESULTS: Of the 124 providers whose serum was tested, 16 (12.9%) were seropositive. Of those providers born in Canada, 8.2% were seropositive, while of those born outside of Canada, 19.6% were positive (P=0.067, OR 2.68, 95% CI 0.91, 7.94). While there was no significant association of seropositivity with age, the association of seropositivity with country of birth was different in the providers under 30 years of age. Among those born in Canada, 4.6% were seropositive, while among those born outside of Canada 23.1% were seropositive.
CONCLUSIONS: The data supplement the limited existing data on toxoplasmosis infection in Canada. Among Canadians, those born outside of Canada were more likely to be seropositive than those born in Canada, suggesting that there may be a differential risk of congenital infection for infants whose parents were born outside of Canada.

Entities:  

Keywords:  Day care; Seroprevalence; Toxoplasmosis

Year:  1996        PMID: 22514458      PMCID: PMC3327420          DOI: 10.1155/1996/172651

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  10 in total

Review 1.  Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States.

Authors:  T Roberts; J K Frenkel
Journal:  J Am Vet Med Assoc       Date:  1990-01-15       Impact factor: 1.936

2.  Exposure to Toxoplasma gondii and cat ownership in Nova Scotia.

Authors:  L H Pereira; M Staudt; C E Tanner; J A Embil
Journal:  Pediatrics       Date:  1992-06       Impact factor: 7.124

3.  The seroepidemiology of toxoplasmosis in the lower Fraser Valley of British Columbia.

Authors:  E M Proctor; S N Banerjee
Journal:  Can J Infect Dis       Date:  1994-09

Review 4.  Toxoplasmosis in pregnancy.

Authors:  S Y Wong; J S Remington
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

5.  Results of 20-year follow-up of congenital toxoplasmosis.

Authors:  J G Koppe; D H Loewer-Sieger; H de Roever-Bonnet
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

6.  Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.

Authors:  J McAuley; K M Boyer; D Patel; M Mets; C Swisher; N Roizen; C Wolters; L Stein; M Stein; W Schey
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

7.  Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

Authors:  C B Wilson; J S Remington; S Stagno; D W Reynolds
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

8.  Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.

Authors:  N G Guerina; H W Hsu; H C Meissner; J H Maguire; R Lynfield; B Stechenberg; I Abroms; M S Pasternack; R Hoff; R B Eaton
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

9.  Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.

Authors:  P Hohlfeld; F Daffos; P Thulliez; C Aufrant; J Couvreur; J MacAleese; D Descombey; F Forestier
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406

10.  Congenital toxoplasmosis: epidemiologic features and control.

Authors:  A O Carter; J W Frank
Journal:  CMAJ       Date:  1986-09-15       Impact factor: 8.262

  10 in total
  2 in total

1.  Common questions about the diagnosis and management of congenital toxoplasmosis.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-03       Impact factor: 2.253

2.  Seroprevalence of cytomegalovirus, Toxoplasma gondii, syphilis, and hepatitis B and C virus infections in a regional population seropositive for HIV infection.

Authors:  D G Johns; M J Gill
Journal:  Can J Infect Dis       Date:  1998-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.